Biomaterial Database

The use of halcinonide solution, 0.1 percent, in the treatment of eczematous diseases. 1983

Y L Lynfield

Halcinonide solution, 0.1 percent, was used to treat sixty-six patients with eczematous dermatoses. The majority of the responses were excellent, with the condition clearing completely in eight patients within the first week. The total mean amount of medication used by each patient for twice a day application for one or two weeks was less than 24 ml.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D011146	Eczema, Dyshidrotic	A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed)	Eczema, Vesicular Palmoplantar,Pompholyx,Vesicular Palmoplantar Eczema,Eczema, Dyshydrotic,Dyshidrotic Eczema,Dyshidrotic Eczemas,Dyshydrotic Eczema,Dyshydrotic Eczemas,Eczemas, Dyshidrotic,Eczemas, Dyshydrotic,Eczemas, Vesicular Palmoplantar,Palmoplantar Eczema, Vesicular,Palmoplantar Eczemas, Vesicular,Vesicular Palmoplantar Eczemas
D011282	Pregnenediones	Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.	Diketopregnenes,Dioxopregnenes
D003872	Dermatitis	Any inflammation of the skin.	Dermatitides
D004485	Eczema	A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents.	Dermatitis, Eczematous,Eczematous Dermatitis
D005260	Female		Females
D006206	Halcinonide	A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.	Alcinonide,Dermalog,Halciderm,Halcimat,Halog,SQ-18,566,SQ 18,566,SQ18,566
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D012628	Dermatitis, Seborrheic	A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.	Seborrhea,Dermatitis Seborrheica,Seborrheic Dermatitis,Dermatitides, Seborrheic,Seborrheic Dermatitides